So they don't need to do anything, why are you questioning why they aren't buying on the market at lower the CR???? And again it isn't a detriment after the release of further positive clinical trial updates in the next 3-6 months as they will convert at premium but it will affect the traders and ST as it will cap the re-rate if they haven't invest in IMU and sell on the re-rate.
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)